Navigation Links
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Date:5/26/2008

First and Only Treatment for Hunter Syndrome Now Approved in 40 Countries

Worldwide

BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May 27 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that ELAPRASE(R) (idursulfase), a human enzyme replacement therapy for the treatment of Hunter syndrome, has been approved by the Brazilian Regulatory Agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA). ELAPRASE, developed by Shire Human Genetic Therapies (HGT), a business unit of Shire focused on genetic diseases, is the first and only enzyme replacement therapy approved for people suffering from Hunter syndrome. Brazil is the largest economy in Latin America and the ninth largest in the world[1]. With this approval, ELAPRASE is now cleared for marketing in two countries in the region - Brazil and Mexico.

Hunter syndrome, also known as Mucopolysaccharidosis II (MPS II), is a serious, life-threatening genetic condition mainly affecting males that results from an absence of, or deficiency in, the lysosomal enzyme iduronate-2-sulfatase. Without sufficient amounts of this enzyme, cellular waste products accumulate in tissues and organs, which then begin to malfunction, leading to severe clinical complications and early mortality. ELAPRASE, which is given as a weekly infusion, is designed to replace the deficient iduronate-2-sulfatase enzyme.

"Approval of ELAPRASE in Brazil further demonstrates our commitment to bringing meaningful treatments to patients across Latin America - and the world," said Sylvie Gregoire, President of Shire HGT.

"This is a tremendous milestone for the many Hunter syndrome patients in Brazil, who will now have access to treatment for this serious and life-threatening disease," said Professor Roberto Giugliani, MD, PhD, Hospital de Clinicas de Porto Alegre. "With ELAPRASE, physicians will now be able to move pat
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
2. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
3. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
4. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
5. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
6. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
7. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
8. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
9. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
10. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
11. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Mass. , June 18, 2013 Decision Resources, ... pharmaceutical and healthcare issues, finds that, over the past 12 ... France , Germany , ... the United Kingdom ) have been required ... of their HIV patients, primarily to reduce costs. Additionally, more ...
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... 18, 2013 Remedy Informatics, a leading ... life sciences research, today announced it has been ... Schedule 70 supply contract (GS-35F-367AA, effective May 7, ... IT solutions to government agencies at federal, state ... Remedy has placed its products and services on ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4
... Profil™ Institute for Clinical Research, Inc., a company specializing in early ... Marcus Hompesch , the company,s President and CEO, will serve as ... Diabetes, the American Diabetes Association,s ( ADA ) largest fund-raising event. ... Dr. Hompesch will help ...
... ROTTERDAM, The Netherlands , July 8, 2010 , ... - Novel Platform Set to Transform Human Therapeutic ... arGEN-X, ... proprietary SIMPLE,Antibody(TM) platform, announces that it has been granted the first patent,covering the platform. ...
Cached Medicine Technology:Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 2Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 2arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 4
(Date:6/19/2013)... 19, 2013 According to Vanessa Grigoriadis, ... called “psychonauts” are creating new designer drugs featuring psychoactive ... of published documents and patented formulas. She reported her ... Now on June 4. , “Some of these ... never tested on humans. Maybe some of them are ...
(Date:6/19/2013)... The Report "Data Center Security Market [Logical ... UTM, IAM, SIEM, DR, ILM); Physical Security (PSIM, ... Forecasts & Analysis (2013-2018)", defines and segments the ... with in-depth analysis and forecasting of revenues. It ... with insights into trends, opportunities, and challenges. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Tools4ever, a ... sponsoring today's event, at which it will be giving ... well as giving further insight into its leading-edge solutions. ... IT & business professionals specialising in IDM infrastructure and ... of markets including the public sector, banking, finance and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Recovery Associates, ... upon crystal meth addiction treatment, helping men and women ... drug. , Crystal meth is a stimulant named for ... drug is most commonly smoked, but it can also ... commonly created in homemade labs using common household ingredients ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US ... test that has been specifically designed to help a recipient ... if their blood contains elevated levels of cobalt, and chromium, ... to see how the device is doing. In the event ... explain the possible options the person will need to consider, ...
Breaking Medicine News(10 mins):Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4Health News:Crystal Meth Addiction Treatment and Crystal Meth Drug Rehab Announced by Recovery Associates 2Health News:US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed 2
... want doctors to be ready to handle medical problems and ... //In the present state, what happens when a person develops ... back to normal conditions for treatment in time simply because ... from a UF study show there is little difference in ...
... has not yet been discovered. Currently,its diagnosis means, high-dose ... the cancer – a watch and wait approach. Recently, ... Belgium explored the possibility of providing patients with continuous ... be published in the November 15, 2006, issue of ...
... to open in Bihar as two US and six Indian ... ,"The Bihar State Investment Promotion Board (SIPB) has ... private sector," said a state official on condition of anonymity. ... in the health sector," he added. ,According to ...
... policymakers to ensure equal access to treatment and livelihood ... social vulnerability., ,"It is imperative to see that ... get equal opportunities to access treatment," stated the National ... on 'Gender impact of HIV and AIDS in India', ...
... million pounds have been pledged to mental hospitals around ... for inmates. A report published early this year by// ... incidents of attempted rape and specifically mentioned 19 incidents ... has catapulted this decision from the government. ...
... Infant Death Syndrome (SIDS) or 'cot death' that kills about ... a defect in the brain, scientists have said.// ... in the US compared the brains of cot death victims ... conditions. , ,They discovered a defect in the brain ...
Cached Medicine News:Health News:Researchers explore medicine in space 2Health News:Researchers explore medicine in space 3Health News:Fighting cancer - Multiple Myeloma with long-term therapy 2Health News:Equal Opportunities For HIV-Positive Women Urged 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: